HENLIUS REPORTS POSITIVE RESULTS FROM ASTRIDE U.S. BRIDGING STUDY FOR SERPLULIMAB IN COMBINATION WITH CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER (ES-SCLC)

Reuters · 4d ago

Please log in to view news